Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Imber

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Transplantation and Cellular Therapy|January 1, 2023
Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell TherapyHarper Hubbeling, Emily A Silverman, Laure Michaud, et al.
JAMA Oncology|September 4, 2025
Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical TrialJonathan T Yang, Divya Yerramilli, Elena Pentsova, et al.
Blood Advances|June 11, 2024
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomasGustav Y Cederquist, Javin Schefflein, Sean M Devlin, et al.
JCO Global Oncology|December 15, 2025
Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional ContextsErin Jay G Feliciano, Urvish Jain, Edward Christopher Dee, et al.
Blood Cancer Journal|April 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphomaAlejandro Luna, Sean M Devlin, Kai Rejeski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2024
Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell LymphomaHarper Hubbeling, Doris Leithner, Emily A Silverman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)Luke R G Pike, Emily Miao, Lillian A Boe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 6, 2022
Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015)Yunpeng Wu, Xin Liu, Brandon S Imber, et al.
Journal of Hematology & Oncology|April 22, 2024
Conventional and novel [<sup>18</sup>F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphomaDoris Leithner, Jessica R Flynn, Sean M Devlin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2025
An International Lymphoma Radiation Oncology Group Study of Radiation Therapy for Bilateral Indolent Orbital Adnexal LymphomasKrystel Tran, Dongryul Oh, Richard Tsang, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Transplantation and Cellular Therapy|January 1, 2023
Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell TherapyHarper Hubbeling, Emily A Silverman, Laure Michaud, et al.
JAMA Oncology|September 4, 2025
Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical TrialJonathan T Yang, Divya Yerramilli, Elena Pentsova, et al.
Blood Advances|June 11, 2024
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomasGustav Y Cederquist, Javin Schefflein, Sean M Devlin, et al.
JCO Global Oncology|December 15, 2025
Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional ContextsErin Jay G Feliciano, Urvish Jain, Edward Christopher Dee, et al.
Blood Cancer Journal|April 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphomaAlejandro Luna, Sean M Devlin, Kai Rejeski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2024
Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell LymphomaHarper Hubbeling, Doris Leithner, Emily A Silverman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)Luke R G Pike, Emily Miao, Lillian A Boe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 6, 2022
Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015)Yunpeng Wu, Xin Liu, Brandon S Imber, et al.
Journal of Hematology & Oncology|April 22, 2024
Conventional and novel [<sup>18</sup>F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphomaDoris Leithner, Jessica R Flynn, Sean M Devlin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2025
An International Lymphoma Radiation Oncology Group Study of Radiation Therapy for Bilateral Indolent Orbital Adnexal LymphomasKrystel Tran, Dongryul Oh, Richard Tsang, et al.
Pageof 11